RWJ 333369
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for RWJ 333369, covering 2012-06-18 to 2013-06-18. Get the full timeline:
Most recent: Clinical Trial Update: An Open-Label Extension Study to Evaluate the Safety and Tolerability of RWJ 333369 as Adjunctive Therapy in Patients 16 Years and Older With Partial Onset Seizures. [Phase 3]